Category II Management Algorithm RegistrationPeriGen2019-12-16T20:27:37+00:00
Category II Management Algorithm App
PLEASE FILL OUT THE FORM TO ACCESS THE CATEGORY II MANAGEMENT ALGORITHM. PLEASE NOTE THAT BY COMPLETING AND SUBMITTING THIS FORM, YOU ARE AGREEING TO THE TERMS SHOWN BELOW. Registration is required on a per device basis.
The Category II Management App, a free web-based app offered exclusively by PeriGen, is based on published research and designed for US usage to help support the management of patients with FHR tracings in category II (present in over 80% of labors).
Only 4-8 clicks get you the suggested outcome and the app takes seconds to use.
Answer a few questions about the tracing and labor status
The application processes the data through the algorithm and presents its conclusion along with the publication’s original image.
This online app (not for download) can be used as often as needed on any computer or mobile device.
A Message from Thomas Garite, MD Chief Medical Officer:
“Category II fetal heart rate tracings are common and cover a wide spectrum ranging from relatively minor findings to more significant combinations that require very different clinical management. This app based on a researched algorthm represents a practical set of management guidelines for clinicians to consider as they care for women in labor. The algorithm was designed in accordance with a fundamental premise in patient safety circles – that standardization and simplification of critical care processes promote better outcomes. Please do read the full publication that describes a number of important concepts that clinicians must also include in their clinical reasoning. No simple algorithm can handle every unusual circumstances or rapid change in the tracing. We look forward to your feedback and hope it will be a useful tool for clinicians to access on their smart phones when managing patients whose tracings are in Category II.”
“We present an algorithm for the management of category II FHR patterns that reflects a synthesis of available evidence and current scientific thought. Use of this algorithm represents one way for the clinician to comply with the standard of care, and may enhance our overall ability to define the benefits of intrapartum FHR monitoring.”
Reference Publication: Intrapartum management of category II fetal heart rate tracings: towards standardization of care. Clark SL,Nageotte MP, Garite TJ, Freeman RK, Miller DA, Simpson KR, Belfort MA, Dildy GA, Parer JT, Berkowitz RL, D’Alton M, Rouse DJ, Gilstrap LC, Vintzileos AM, van Dorsten JP, Boehm FH, Miller LA, Hankins GD. Am J Obstet Gynecol. 2013 Aug;209(2):89-97. doi: 10.1016/j.ajog.2013.04.030. Epub 2013 Apr 27 http://www.ncbi.nlm.nih.gov/pubmed/23628263
In the parent publication, the authors discuss important issues to consider when using the algorithm. We strongly encourage everyone to read the original article in full. For you convenience brief outlines are listed here:
The Category II Management App algorithm follows NICHD definitions
This algorithm should be viewed as a one next step in management recommendations
The goal is to deliver the baby prior to any damage from asphyxia
Non operative interventions may be appropriately used and an effect should be apparent within 30 min.
Baseline variability and loss of accelerations will be reliably depressed before the pH has reached a level associated with damage
FHR patterns cannot be interpreted in isolation – labor progress must be considered
Some well-defined features of Category II are not included in the algorithm
Sentinel events can occur without warning. Clinical situations exist where Category II may be harbingers of sentinel events and more prompt action may be appropriate, such as Vaginal bleeding and TOLAC
The algorithm does not address recurrent prolonged decelerations
A given fetus may have experience more than one pathologic process concurrently
The algorithm authorizes judgment between CS and operative vaginal delivery
We caution against delay in delivery for a deteriorating FHR pattern because criteria indicating probable severe metabolic acidemia have not yet been met- minimal and absent variability are treated the same way.
A fetus with minimal/absent variability without decelerations presents a diagnostic and management dilemma
The algorithm used by the Category II Management App represents a consensus of 18 authors
The algorithm is supported by a substantial body of research
Usage is for United States only.
BEFORE INSTALLING AND USING THE APPLICATION AND UNDERLYING TECHNOLOGY WHICH YOU HAVE DOWNLOADED (“APPLICATION”) YOU SHOULD CAREFULLY READ THE FOLLOWING LICENSE AGREEMENT (“AGREEMENT”) THAT APPLIES TO THE APPLICATION. CLICK “I AGREE” IF YOU FULLY ACCEPT AND AGREE TO ALL OF THE PROVISIONS OF THIS AGREEMENT. OTHERWISE, CLICK “CANCEL.” CLICKING “I AGREE” OR OTHERWISE DOWNLOADING, INSTALLING AND/OR USING THE APPLICATION ESTABLISHES A BINDING AGREEMENT BETWEEN YOU AS THE PERSON LICENSING THE APPLICATION, EITHER ON BEHALF OF YOURSELF OR ANY THIRD PARTY ENTITY (THE “LICENSEE”) AND PERIGEN, INC. (“PERIGEN”). IF YOU DO NOT ACCEPT ALL OF THE TERMS OF THIS AGREEMENT, YOU SHALL HAVE NO RIGHT TO DOWNLOAD, INSTALL AND/OR USE THE APPLICATION AND MUST DELETE THE APPLICATION AND ASSOCIATED FILES IMMEDIATELY. BY INSTALLING AND/OR BY USING THE APPLICATION, YOU REPRESENT AND WARRANT THAT YOU HAVE THE LEGAL CAPACITY AND AUTHORITY TO ENTER INTO A BINDING AGREEMENT TO ADHERE TO THE TERMS AND CONDITIONS SET FORTH HEREIN, AND THAT THE APPLICATION WILL BE USED ONLY IN ACCORDANCE WITH THESE TERMS AND CONDITIONS AND WITH ALL APPLICABLE LAWS. IF AN INDIVIDUAL IS REGISTERING OR USING THE APPLICATION ON BEHALF OF AN ENTITY OR ORGANIZATION, THAT INDIVIDUAL WARRANTS, REPRESENTS, AND COVENANTS TO PERIGEN THAT SUCH INDIVIDUAL IS DULY AUTHORIZED TO AGREE TO THESE TERMS AND CONDITIONS ON BEHALF OF THE ORGANIZATION AND TO BIND THE ORGANIZATION TO THEM. Grant of License. You may use the Application for your internal business purposes only. Restrictions. You may not use the Application for any unlawful purpose. You may not forward, modify, adapt, translate, or prepare derivative works from the Application, or decompile, reverse engineer, disassemble or otherwise attempt to derive source code from the Application, or remove, obscure, or alter any trademarks or copyright or other proprietary rights notices affixed to or contained within or accessed in conjunction with or through the Application. Termination. This Agreement is effective upon your download of the Application, and remains effective until terminated. This license will terminate immediately without notice from PeriGen or judicial resolution if you fail to comply with any provision of this Agreement. Upon such termination you must destroy the Application, all accompanying written materials and all copies thereof, and the sections entitled Limited Warranty, Limitation of Remedies and Damages, and General will survive any termination. Disclaimer. YOU ACKNOWLEDGE THAT (I) PERIGEN IS NOT ASSUMING ANY PROFESSIONAL RESPONSIBILITY FOR PATIENTS OR PATIENT CARE, INCLUDING RESPONSIBILITIES THAT WOULD REQUIRE OR PERMIT PERIGEN TO ENGAGE IN THE PRACTICE OF MEDICINE; (II) THE APPLICATION IS NOT INTENDED TO SUBSTITUTE FOR, OR TO REPLACE, THE SKILL, KNOWLEDGE AND EXPERIENCE OF LICENSED PHYSICIANS OR OTHER CARE PROVIDERS; (III) PERIGEN IS NOT PROVIDING THE APPLICATION HEREUNDER TO YOU AS A SUBSTITUTE OR REPLACEMENT FOR THE MEDICAL JUDGMENT OF THE YOUR PHYSICIANS OR OTHER CARE PROVIDERS; AND (IV) PERIGEN HAS NO AND DISCLAIMS ANY RESPONSIBILITY WHATSOEVER FOR, AND YOU RELEASE PERIGEN FROM ANY DAMAGES ARISING FROM OR RELATED TO, THE CONDUCT OF YOUR BUSINESS OR PATIENT CARE, AND ANY RELIANCE UPON THE APPLICATION SHALL NOT DIMINISH YOUR RESPONSIBILITY FOR PATIENT CARE. YOU SHALL BE SOLELY RESPONSIBLE FOR THE ACCURACY AND ADEQUACY OF INFORMATION AND DATA FURNISHED BY IT FOR PROCESSING AND ANY USE MADE BY YOU OR YOUR STAFF OF THE OUTPUT OF THE APPLICATION OR ANY RELIANCE THEREON. Limitation of Remedies and Damages. Regardless of whether any remedy set forth herein fails of its essential purpose, IN NO EVENT SHALL PERIGEN OR ANY OF ITS AFFILIATES, OR THEIR LICENSORS, DIRECTORS, OFFICERS, EMPLOYEES OR AGENTS BE LIABLE TO YOU FOR ANY CONSEQUENTIAL, INCIDENTAL, INDIRECT, SPECIAL, PUNITIVE OR SIMILAR DAMAGES WHATSOEVER (including, without limitation, damages for loss of business profits, business interruption, loss of business information and the like), whether foreseeable or unforeseeable, arising out of the use or inability to use the Application or accompanying written materials, regardless of the basis of the claim, even if PeriGen has been advised of the possibility of such damage. PeriGen’s total liability to you, for direct damages for any cause whatsoever, regardless of the basis of the form of action, will be limited to $100.00. General. This Agreement shall be governed by the laws of the State of New Jersey, exclusive of its conflicts of laws provisions and without regard to the United Nations Convention on Contracts for the International Sale of Goods, and any suit under this Agreement shall exclusively be brought in a federal or state court in New Jersey. The delay or failure of either party to exercise any right provided in the Agreement shall not be deemed a waiver. All notices must be in writing and shall be delivered by hand (effective when received) or mailed by registered or certified mail (effective on the third day following the date of mailing). If for any reason a court of competent jurisdiction finds any provision or portion of this Agreement to be unenforceable, the remainder of this Agreement will continue in full force and effect. This Agreement, constitutes the entire agreement between the parties with respect to the subject matter hereof and supersedes and replaces all prior or contemporaneous understandings or agreements, written or oral, regarding such subject matter. Any amendment to any provision of this Agreement will be effective only if in writing and signed by both parties.